Last deal

$7.5M

Amount

Series B

Stage

30.05.2023

Date

3

all rounds

$38.25M

Total amount

date founded

Financing round

General

About Company
The company 410 Medical has developed a device that allows healthcare providers to deliver fluids to critically ill patients.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company's rapid infuser device, called LifeFlow® PLUS, enhances the speed and efficiency of fluid resuscitation, improving care for patients with life-threatening illnesses such as sepsis and shock. It allows for fast set-up, minimizes provider fatigue, and frees up providers to address other patient care issues simultaneously. This solution is particularly useful in pre-hospital settings and the emergency department where speed is critical and resources may be limited. Founded in 2013 and headquartered in Durham, North Carolina, 410 Medical is a medical device company dedicated to developing innovative products that enable clinicians to improve care for critically ill patients.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
CoapTech

CoapTech

CoapTech is an early-stage medical device company that aims to improve medical care delivery worldwide.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

Location

Baltimore, MD, USA

total rounds

8

total raised

$15.39M
Rapid Medical

Rapid Medical

Rapid Medical is a company that develops safe and effective neurovascular medical devices.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Yokne'am Illit, Israel

total rounds

3

total raised

$79M
Lineus Medical

Lineus Medical

Lineus Medical develops medical devices to reduce IV complications and improve patient outcomes.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Fayetteville, AR, USA

total rounds

9

total raised

$7.74M
ThrombX Medical

ThrombX Medical

ThrombX Medical is a company that develops innovative devices to improve outcomes for patients with ischemic stroke.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

San Mateo, CA, USA

total rounds

1

Financials

Funding Rounds
12
3

Number of Funding Rounds

$38.25M

Money Raised

Their latest funding was raised on 30.05.2023. Their latest investor Catalyst by Wellstar. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Hatteras Venture Partners

Hatteras Venture Partners

Hatteras Venture Partners invests in transformative companies in healthcare and related fields.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Keywords

Venture Capital, Health Care, Financial Services

Location

Durham, NC, USA

count Of Investments

96

count Of Exists

16
Hatteras Venture Partners

Hatteras Venture Partners

Hatteras Venture Partners invests in transformative companies in healthcare and related fields.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Keywords

Venture Capital, Health Care, Financial Services

Location

Durham, NC, USA

count Of Investments

96

count Of Exists

16
One North Carolina Small Business Program

One North Carolina Small Business Program

NC Small Business Program grants state funding to innovative companies developing high-potential technologies.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Information Technology

Location

Raleigh, NC, USA

count Of Investments

99

count Of Exists

1
Co-Investors
Investors
16
6

Number of lead investors

16

Number of investors

Investor 
Lead 
Round 
Partners 
Catalyst by Wellstar

Catalyst by Wellstar

Catalyst by Wellstar builds better healthcare through innovation and partnerships.

Sector

Health Care Providers

Subsector

Health Care Services

Location

Atlanta, GA, USA

count Of Investments

1
Orlando Health Ventures

Orlando Health Ventures

Orlando Health Strategic Innovations aims to actualize ideas, concepts, and inventions originating from our team members and physicians.

Sector

Health Care Providers

Subsector

Health Care Services

count Of Investments

8
Bobby Helmedag

Bobby Helmedag

Bobby oversees the day-to-day operations of the fund. Bobby serves as the Rex Health Ventures Board representative for Midnight Pharma, Target PharmaSolutions and Phynd Technologies as well as having Board observer roles with Aerial BioPharma and Awarepoint. He joined UNC REX Healthcare in 2010. Previously, Bobby worked for BlueCross BlueShield of Tennessee in the Corporate Development group. He has also held positions with an investor group in Columbia, S.C., Citigroup and KPMG. Bobby received his International MBA from the Moore School of Business at the University of South Carolina, studying in Germany, England and Australia. He received his undergraduate degree in finance from the University of Notre Dame.

current job

Rex Health Ventures
Rex Health Ventures
Ballad Ventures

Ballad Ventures

Ballad Ventures is a subsidiary of Ballad Health that invests in innovative healthcare solutions.

Sector

Health Care Providers

Subsector

Health Care Management Services

Keywords

Health Care, Non-Profit, Venture Capital

count Of Investments

4

People

Founders
2
Mark Piehl
Mark Piehl

Mark Piehl

current job

410 Medical
410 Medical

organization founded

1

Mark Piehl

Luke Roush
Luke Roush

Luke Roush

Luke Roush co-founded 410 Medical alongside Dr. Piehl in 2013. He is currently a Managing Principal of Sovereign’s Capital, the venture capital firm which he co-founded in 2012. Previously, Luke has twelve years of experience in global commercialization and business development at venture-backed and Fortune 500 companies. He was Vice President for Sales, Marketing, and Business Development at TransEnterix, a medical device company that developed and commercialized a minimally invasive surgical system in the US, Europe, and Middle East. Prior to joining TransEnterix, he served as Chief Operating Officer at Liquidia Technologies, a nanotechnology company focused on biopharmaceutical applications. Mr. Roush was also global marketing manager for Boston Scientific’s neurovascular stroke business. Mr. Roush graduated summa cum laude from Duke University, and earned his MBA from The Fuqua School of Business.

current job

Sovereign’s Capital
Sovereign’s Capital

Luke Roush

Employee Profiles
6

Mike Russell

Vice president of sales

Kyle Chenet

Kyle Chenet

CEO

Mark Piehl

Mark Piehl

Co-founder & CMO

Galen Robertson

Galen Robertson

Chief Operating Officer

Luke Roush

Luke Roush

Co-Founder

Jeff Terrell

Jeff Terrell

Board of Directors

Activity

Recent News
0